《2025年香港IPO及二级市场白皮书》发布：港股强势复苏，硬科技与生物医药成新引擎

Group 1: IPO Market Performance - In 2025, the Hong Kong IPO market raised HKD 286.7 billion, a significant increase of 225.9% year-on-year, reclaiming the top position globally for fundraising [2] - A total of 114 companies went public in 2025, marking a 62.9% increase compared to 2024 [2] - The number of mega IPOs (raising over HKD 10 billion) reached 8, a sevenfold increase from 2024 [2][3] Group 2: Industry and Regional Insights - The healthcare sector led the IPO market with 28 listings, reflecting a 133.3% year-on-year growth, indicating strong investor interest in biotech companies [5] - Mainland companies dominated the Hong Kong IPO market, with Shanghai surpassing Guangdong as the city with the most IPOs, totaling 18 [5] Group 3: Market Sentiment and Performance - The IPO subscription market saw unprecedented enthusiasm, with 14 million subscriptions, a more than 12-fold increase from the previous year, and an average oversubscription rate of 1,684 times [9] - 90.28% of new stocks were issued at a premium, showcasing strong market confidence [9] - The first-day drop rate for new stocks fell below 30%, with an average first-day increase of 36.95% [11] Group 4: Secondary Market Dynamics - The Hong Kong secondary market outperformed globally, with the Hang Seng Index rising by 27.77% in 2025, leading major global indices [12] - Daily trading volume averaged approximately HKD 248.9 billion, an 88.7% increase year-on-year [12] Group 5: Capital Flow and Structural Changes - Southbound capital became a key source of liquidity for Hong Kong stocks, with total transactions reaching HKD 28.7 trillion and net purchases exceeding HKD 1.4 trillion, both setting historical records [14] - The Hong Kong Stock Exchange implemented reforms to lower barriers for tech companies, facilitating a shift towards hard tech, biotech, and new consumption sectors [15]